InvestSMART

ImpediMed Limited (ASX: IPD) - Share Price

- Current share price for IPD : $0.005

ImpediMed Limited's current share price is $0.01. This constitutes a share price movement of 25% when compared to its closing share price of $0.00 seven days ago. Relative to today's opening stock price, the IPD stock price is unchanged.

IPD General Information +

ASX Code IPD
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 18
IPD Share Price $0.005
Day High $0.005
Day Low $0.005
Last Close $0.005
IPD Share Price Movement - ( No change )
Prices as at 16:40, 20 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

ImpediMed Limited (IPD) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from ImpediMed Limited (IPD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

ImpediMed Limited (IPD) price-sensitive announcements

IPD - Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr
ImpediMed Limited’s Quarterly Activities Report and Appendix 4C for the quarter ended 30 S
ImpediMed Limited (IPD)
30 Oct 2026 | 8:21 AM
IPD - Appendix 4E
ImpediMed Limited announced its Appendix 4E Preliminary Final Report for the financial yea
ImpediMed Limited (IPD)
27 Aug 2026 | 11:03 AM
IPD - Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
ImpediMed Limited reported a strong performance in Q4 FY26, with revenues growing to $3.6
ImpediMed Limited (IPD)
28 Jul 2026 | 8:31 AM
IPD - Oversubscribed Share Purchase Plan Successfully Completed
ImpediMed Limited announced the successful completion of its oversubscribed Share Purchase
ImpediMed Limited (IPD)
10 Jun 2026 | 9:05 AM

ImpediMed Limited (IPD) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
ImpediMed Limited (IPD)
ORDINARY FULLY PAID
Health Care $18 2026 AGM - Results of Meeting 18 Nov 2026 4:29PM $0.005 $0.005 fallen by 0%
ImpediMed Limited (IPD)
ORDINARY FULLY PAID
Health Care $18 2026 AGM - CEO's Presentation 18 Nov 2026 10:42AM $0.004 $0.005 risen by 25%
ImpediMed Limited (IPD)
ORDINARY FULLY PAID
Health Care $18 2026 AGM - Chair's Address 18 Nov 2026 10:41AM $0.004 $0.005 risen by 25%
ImpediMed Limited (IPD)
ORDINARY FULLY PAID
Health Care $18 Investor Presentation 30 Oct 2026 8:25AM $0.005 $0.005 risen by 11.11%
ImpediMed Limited (IPD)
ORDINARY FULLY PAID
Health Care $18 Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr 30 Oct 2026 8:21AM $0.005 $0.005 risen by 11.11%
ImpediMed Limited (IPD)
ORDINARY FULLY PAID
Health Care $18 Change of Director's Interest Notice - Mr Andrew Grant 28 Oct 2026 2:03PM $0.004 $0.005 risen by 25%

IPD Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2028F C2 -$0.20 -33.30% 0.00 0.00 0.00% 0.0%
2027F C2 -$0.30 -74.40% 0.00 0.00 0.00% 0.0%
2026A -$24.91 -$1.20 1.70% 0.00 0.00 0.00% 0.0%

IPD Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2026 A 2027 F 2028 F 2026 A 2027 F 2028 F 2026 A 2027 F 2028 F
Cochlear Limited (COH) $10,063M -0.3136 0.2540 0.0785 37.4607 29.8730 27.6989 2.24% 2.33% 2.53%
Fisher & Paykel Healthcare Corporation Limited (FPH) $23,889M 0.1388 0.1474 0.1575 61.4093 53.5187 46.2370 1.07% 1.16% 1.29%
Imricor Medical Systems Inc (IMR) $470M -0.4254 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ImpediMed Limited (IPD) $18M 0.0174 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed Inc. (RMD) $20,370M 9.5922 0.1126 0.0881 23.6413 21.2489 19.5280 0.98% 1.04% 1.12%

IPD Directors

Name Position Start Date
Mr McGregor Grant Executive Director, Chief Financial Officer 28 Sep 2023
Mr Andrew John Grant Non-Executive Director 28 Sep 2023
Ms Janelle Delaney Non-Executive Director 28 Sep 2023
Ms Fiona Bones Non-Executive Director 7 Jun 2024
Mr Erik Anderson Non-Executive Director 25 Feb 2026
Ms Christine Emmanuel-Donnelly Non-Executive Director, Non-Executive Chairman 28 Sep 2023

ImpediMed Limited (IPD) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Oct 2026 DELANEY, Janelle Issued Direct Shares 776,087 $0.005 $3,570.000
27 Oct 2026 BONES, Fiona Issued Direct Shares 776,087 $0.005 $3,570.000
27 Oct 2026 EMMANUEL-DONNELLY, Christine Issued Indirect Shares 1,129,891 $0.005 $5,197.499

See all changes in directors' interest & trades for ImpediMed Limited (IPD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IPD Management

Name Position
Leanne Ralph Company Secretary
Blake Ahitow Other Corporate Officer
Erik Johnson Other Corporate Officer
Gina Kimball Other Corporate Officer
Julie Kuhlken Other Corporate Officer
Ashley Munoz Other Executive Officer
Richelle Gaw Other Executive Officer
Scott Savage Other Executive Officer
Chelsey Jaworski Vice President, Divisional
Scott Long Vice President, Divisional

IPD Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in ImpediMed Limited (IPD). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
352,316,011 (9.62%) Paradice Investment Management Pty Ltd
245,454,175 (6.70%) Acorn Capital Limited

IPD Calendar of Events

Date Event
26 August 2027 Report (Annual)
26 August 2027 Report (Prelim)
02 March 2027 Report (Interim)
25 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.